当前位置：
X-MOL 学术
›
Arthritis Rheumatol.
›
论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Disease Flare and Reactogenicity in Patients With Rheumatic and Musculoskeletal Diseases Following Two-Dose SARS–CoV-2 Messenger RNA Vaccination
Arthritis & Rheumatology ( IF 13.3 ) Pub Date : 2021-08-04 , DOI: 10.1002/art.41924 Caoilfhionn M Connolly 1 , Jake A Ruddy 1 , Brian J Boyarsky 1 , Iulia Barbur 1 , William A Werbel 1 , Duvuru Geetha 1 , Jacqueline M Garonzik-Wang 1 , Dorry L Segev 1 , Lisa Christopher-Stine 1 , Julie J Paik 1
Arthritis & Rheumatology ( IF 13.3 ) Pub Date : 2021-08-04 , DOI: 10.1002/art.41924 Caoilfhionn M Connolly 1 , Jake A Ruddy 1 , Brian J Boyarsky 1 , Iulia Barbur 1 , William A Werbel 1 , Duvuru Geetha 1 , Jacqueline M Garonzik-Wang 1 , Dorry L Segev 1 , Lisa Christopher-Stine 1 , Julie J Paik 1
Affiliation
To evaluate disease flare and postvaccination reactions (reactogenicity) in patients with rheumatic and musculoskeletal diseases (RMDs) following 2-dose SARS–CoV-2 messenger RNA (mRNA) vaccination.
中文翻译：
风湿病和肌肉骨骼疾病患者接种两剂 SARS–CoV-2 信使 RNA 疫苗后的疾病发作和反应原性
评估风湿病和肌肉骨骼疾病 (RMD) 患者接种 2 剂 SARS-CoV-2 信使 RNA (mRNA) 疫苗后的疾病发作和疫苗接种后反应（反应原性）。
更新日期：2021-08-04
中文翻译：
风湿病和肌肉骨骼疾病患者接种两剂 SARS–CoV-2 信使 RNA 疫苗后的疾病发作和反应原性
评估风湿病和肌肉骨骼疾病 (RMD) 患者接种 2 剂 SARS-CoV-2 信使 RNA (mRNA) 疫苗后的疾病发作和疫苗接种后反应（反应原性）。
京公网安备 11010802027423号